The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...

Bread and biscuits made from Crispr-edited wheat showed substantially reduced acrylamide levels Scientists have developed gene-edited wheat that can be used to make bread that is less carcinogenic ...

In 1976, Richard Dawkins published a book titled after an idea he’d come up with while teaching a lecture on animal behaviour for his PhD supervisor. It just so happened that the idea of The Selfish ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

This article is part of a Health Affairs Forefront featured topic, Medicaid Financing. Which includes analysis, proposals, and commentary that will inform policies on the state and federal levels to ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...

GM1 gangliosidosis, caused by biallelic variants in GLB1, results from deficiency of lysosomal β-galactosidase, which degrades GM1 ganglioside. This fatal neurodegenerative disease currently has no ...

We’ve all heard of couch surfing, but Fender and Samsung have made it their 2026 mission to make couch shredding a thing. Samsung TV users will soon be able to take guitar lessons from the comfort of ...

Here’s how extinct DNA could help us in the present—and the future. Yeah, we know—it’s not a dire wolf. In early 2025, the Texas biotech company Colossal Biosciences landed with a splash on the cover ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...